TWiV 1353: Phage bet-hedging and EBV antibodies

This Week in Virology with Vincent Racaniello by Vincent Racaniello

Aug 30, 202601:52:01Religion & Spirituality

TWiV explores how bacteriophages enable bet-hedge against bacterial immune defenses, and how transgenic mice engineered to produce human antibodies yielded potent anti-EBV candidates targeting gp350 and gp42, a promising...

Related Episodes

Continue listening to more episodes from This Week in Virology with Vincent Racaniello.

TWiV 1357: Furin, Naturally with Paul Bieinasz

Sep 13, 2026 - 01:44:17

Paul Bieniasz joins TWiV to discuss his lab’s discovery that the coronavirus nuclease NSP15 cuts viral RN...

TWiV 1356: Clinical update with Dr. Daniel Griffin

Sep 12, 2026 - 47:17

In his weekly clinical update, Daniel Griffin and Vincent Racaniello delve into dengue virus infections i...

TWiV 1355: Four billion years of AI training data

Sep 6, 2026 - 01:38:00

TWiV reviews a landmark paper reporting the first generative design of complete viral genomes using AI, p...

TWiV 1354: Clinical update with Dr. Daniel Griffin

Sep 5, 2026 - 01:05:08

In his weekly clinical update, Daniel Griffin and Vincent Racaniello remember Dolly Parton and her patron...

TWiV 1352: Clinical update with Dr. Daniel Griffin

Aug 29, 2026 - 48:56

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are disheartened by the suggested ch...

TWiV 1351: Ebola Virus Brains and Contagious Catfish Cancers

Aug 23, 2026 - 01:40:49

TWiV describes a human cerebral organoid model for Ebola virus persistence, and brown bullhead catfish me...

TWiV 1350: Clinical update with Dr. Daniel Griffin

Aug 22, 2026 - 01:00:49

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are perplexed by the state of global...

TWiV 1349: Smallpox and mummies

Aug 16, 2026 - 02:02:43

TWiV explains how liquid–liquid phase separation and a phage-encoded inhibitor cooperatively drive transc...